LENZ THERAPEUTICS, INC. Interest Expense, Related Party
LENZ THERAPEUTICS, INC. (LENZ) reported Interest Expense, Related Party of $40.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-21.
Discontinued › Expense Statement
us-gaap:InterestExpenseRelatedParty · last filed 2022-03-21
- LENZ THERAPEUTICS, INC. interest expense, related party for the quarter ending 2020-12-31 was $0.00.
- LENZ THERAPEUTICS, INC. interest expense, related party for the quarter ending 2020-09-30 was $0.00.
- LENZ THERAPEUTICS, INC. interest expense, related party for the quarter ending 2020-06-30 was $20.00K.
- LENZ THERAPEUTICS, INC. interest expense, related party for fiscal 2020 was $40.00K.
| Period end | Interest Expense, Related Party 3 month | Interest Expense, Related Party 6 month | Interest Expense, Related Party 9 month | Interest Expense, Related Party 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $0.00 derived: sum of 2 quarters · filed 2022-03-21 | $20.00K derived: sum of 3 quarters · filed 2022-03-21 | $40.00K 10-K · filed 2022-03-21 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $20.00K derived: sum of 2 quarters · filed 2021-11-10 | $40.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $20.00K 10-Q · filed 2021-08-12 | $40.00K 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |